Correction: Infections in patients with rheumatoid arthritis receiving tofacitinib versus tumour necrosis factor inhibitors: results from the open-label randomised controlled ORAL Surveillance trial

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Correction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10511951/
https://www.ncbi.nlm.nih.gov/pubmed/37726134
http://dx.doi.org/10.1136/ard-2022-222405corr1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10511951/
https://www.ncbi.nlm.nih.gov/pubmed/37726134
http://dx.doi.org/10.1136/ard-2022-222405corr1

Ejemplares similares